Amundi Asset Management US’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-105,515
Closed -$7.03M 547
2016
Q4
$7.03M Sell
105,515
-28,931
-22% -$1.88M 0.02% 349
2016
Q3
$8.91M Sell
134,446
-180,937
-57% -$12.4M 0.03% 333
2016
Q2
$22.8M Buy
315,383
+52,871
+20% +$3.63M 0.08% 193
2016
Q1
$17M Buy
262,512
+22,320
+9% +$1.48M 0.06% 225
2015
Q4
$17.2M Buy
240,192
+67,797
+39% +$5.01M 0.06% 243
2015
Q3
$13.2M Buy
172,395
+19,296
+13% +$1.56M 0.05% 276
2015
Q2
$11.3M Buy
+153,099
New +$11M 0.04% 322

Other funds holding MD

Amundi Asset Management US's MD Position: Q1 2017 in Review

Amundi Asset Management US sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 105,515 shares — an estimated $7.03M sold.

Amundi Asset Management US first reported a position in MD in Q2 2015 and held it in 7 quarters. The position peaked at $22.8M in Q2 2016. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Amundi Asset Management US reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Amundi Asset Management US sold 105,515 Pediatrix Medical shares in Q1 2017, an estimated $7.03M.
  • Amundi Asset Management US first reported a position in Pediatrix Medical in Q2 2015 and held it in 7 quarters.
  • Amundi Asset Management US's Pediatrix Medical position peaked at $22.8M in Q2 2016.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Amundi Asset Management US's 13F filing for Q1 2017, filed 8 May 2017.